Record Details

Catalog Search

Search The Catalog



FDA fast track and priority review programs / Susan Thaul.

Electronic resources

Record details

  • Physical Description: 1 online resource.
  • Edition: [Library of Congress public edition].
  • Publisher: [Washington, D.C.] : Congressional Research Service, 2018-

Content descriptions

General Note:
The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated 2008.
Bibliography, etc. Note:
Report includes bibliographical references.
Source of Description Note:
Description based on contents viewed on Jan. 21, 2020; title from CRS report home page.
Subject:
Drugs > Testing.
Drug approval > United States.
Drug development > United States.
CRS reports (Library of Congress. Congressional Research Service)

Accessibility Features

LDR 02048nai a2200445 i 4500
00114370781
003CARDINAL
00520200124153712.0
006m o d f
007cr mn|||||||||
008200124c20189999dcu x w o b f0 2eng c
010 . ‡a2020230729
035 . ‡a(OCoLC)1137386409
040 . ‡aGPO ‡beng ‡erda ‡epn ‡cGPO
042 . ‡apcc
043 . ‡an-us---
074 . ‡a0807-A-07 (online)
0860 . ‡aLC 14.23:RS 22814/
1001 . ‡aThaul, Susan, ‡eauthor.
24510. ‡aFDA fast track and priority review programs / ‡cSusan Thaul.
2461 . ‡aFood and Drug Administration fast track and priority review programs
250 . ‡a[Library of Congress public edition].
264 1. ‡a[Washington, D.C.] : ‡bCongressional Research Service, ‡c2018-
300 . ‡a1 online resource.
310 . ‡aUpdated irregularly
336 . ‡atext ‡btxt ‡2rdacontent
337 . ‡acomputer ‡bc ‡2rdamedia
338 . ‡aonline resource ‡bcr ‡2rdacarrier
4901 . ‡aReport / Congressional Research Service ; ‡vRS22814
500 . ‡aThe CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated 2008.
504 . ‡aReport includes bibliographical references.
588 . ‡aDescription based on contents viewed on Jan. 21, 2020; title from CRS report home page.
650 0. ‡aDrugs ‡xTesting. ‡0(CARDINAL)236598
650 0. ‡aDrug approval ‡zUnited States. ‡0(CARDINAL)449782
650 0. ‡aDrug development ‡zUnited States.
7102 . ‡aLibrary of Congress. ‡bCongressional Research Service, ‡eissuing body. ‡0(CARDINAL)142410
77308. ‡iContained in (work): ‡tCRS reports (Library of Congress. Congressional Research Service) ‡w(DLC) 2018231131 ‡w(OCoLC)1052784408
830 0. ‡aCRS report ; ‡vRS22814. ‡0(CARDINAL)680247
85640. ‡uhttps://purl.fdlp.gov/GPO/gpo130970 ‡7govdoc ‡yClick for online content. ‡9BHM ‡9BLADEN ‡9BRASWELL ‡9BROWN ‡9BRUNSWICK ‡9BUNCOMBE ‡9BURKE ‡9CALDWELL ‡9CARTERET ‡9CASWELL ‡9CLEVELAND ‡9DAVIE ‡9DUPLIN ‡9FARMVILLE ‡9FORSYTH ‡9FRANKLIN ‡9GRANVILLE ‡9HARNETT ‡9HAYWOOD ‡9HENDERSON ‡9IREDELL ‡9JOHNSTON ‡9LEE ‡9MADISON ‡9MAUNEY ‡9NANTAHALA ‡9NORTHWESTERN ‡9ONSLOW ‡9PERRY ‡9PERSON ‡9POLK ‡9ROBESON ‡9ROCKINGHAM ‡9RUTHERFORD ‡9SAMPSON ‡9SANDHILL ‡9SCOTLAND ‡9STANLY ‡9TRV ‡9WARREN ‡9YANCEY ‡9DEQ_ELC ‡9GHL ‡9GOV_MANSION ‡9HIGH_POINT ‡9NC_ARCHIVES ‡9NC_ART ‡9NC_DOL ‡9NC_DOT ‡9NC_LEG ‡9NC_NATSCI ‡9NC_SHS ‡9CAMDEN ‡9CURRITUCK ‡9DARE ‡9JACKSON ‡9PASQUOTANK
901 . ‡a14370781 ‡bgovdoc-script fb2d61e148210b4ab73b2878ea8b4211fb2fd67a 17bdb6b893333be4f0140ca36e3e15033658af15 ‡c14370781 ‡tbiblio ‡selectronic